Adding another layer to its potential significance, MCP1’s influence on the hypothalamus-pituitary-adrenal (HPA) axis (94), a critical regulator of stress responses and immune function, prompts further exploration into its diagnostic and therapeutic potential for ME/CFS. This evidence concerns the gene CCL2 and myalgic encephalomeyelitis/chronic fatigue syndrome.